Cancer therapeutics for solid tumors remain limited by the low specificity and high rates of multidrug resistance of conventional chemotherapy. Immunotherapy offered a potential solution to these challenges; however, monoclonal antibody treatments have failed ... ...

请注册登录后继续浏览